Compare XBIT & SOTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | XBIT | SOTK |
|---|---|---|
| Founded | 2005 | 1975 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Pharmaceuticals and Biotechnology | Industrial Machinery/Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 74.4M | 73.7M |
| IPO Year | 2015 | 1995 |
| Metric | XBIT | SOTK |
|---|---|---|
| Price | $2.37 | $5.10 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 25.1K | ★ 42.9K |
| Earning Date | 05-08-2026 | 05-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 37.50 |
| EPS | N/A | ★ 0.11 |
| Revenue | N/A | ★ $20,909,315.00 |
| Revenue This Year | N/A | $4.02 |
| Revenue Next Year | N/A | $10.95 |
| P/E Ratio | ★ N/A | $45.55 |
| Revenue Growth | N/A | ★ 1.97 |
| 52 Week Low | $2.09 | $3.23 |
| 52 Week High | $3.61 | $5.74 |
| Indicator | XBIT | SOTK |
|---|---|---|
| Relative Strength Index (RSI) | 48.81 | 49.25 |
| Support Level | $2.35 | $3.79 |
| Resistance Level | $2.41 | $5.15 |
| Average True Range (ATR) | 0.05 | 0.33 |
| MACD | 0.00 | -0.05 |
| Stochastic Oscillator | 40.79 | 23.32 |
XBiotech Inc is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies derived from human donors to replicate the human immune response in the treatment of various diseases. It has developed a pipeline of product candidates using True Human antibodies targeting both inflammatory and infectious diseases. The company's developement pipeline comprises: Natrunix, an antibody targeting IL-1a in oncology (pancreatic cancer), a clinical stage therapeutic for Methicillin Resistant Staphylococcus aureus (MRSA), and several pre-clinical stage therapeutics, including: an oral delivery antibody therapeutic for colon infection by C. difficile; an injectable therapy for varicella zoster (adult chicken pox), the causative agent for shingles; and an influenza therapy.
Sono-Tek Corp design and manufacture of ultrasonic coating systems for applying precise, thin film coatings to add functional properties, protect or strengthen surfaces on parts and components for the microelectronics/electronics, alternative energy, medical, industrial and emerging research & development/other markets. The company design and manufacture custom-engineered ultrasonic coating systems incorporating its patented technology, in combination with strong applications engineering knowledge, to assist its customers in achieving their desired coating solutions.